Letter to the Editor Regarding “Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden” by Martin et al. (2026)
Pharmacoepidemiology and Drug Safety · 2026-11 · 35 (11)
DOI: 10.1002/pds.70519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 18.11.2026. Verfasst von Pierre Desaunay und 2 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Desaunay, P., Blouet, C., & Guenole, F. (2026). Letter to the Editor Regarding “Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden” by Martin et al. (2026). Pharmacoepidemiology and Drug Safety, 35(11). https://doi.org/10.1002/pds.70519
Vancouver
Desaunay P, Blouet C, Guenole F. Letter to the Editor Regarding “Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden” by Martin et al. (2026). Pharmacoepidemiology and Drug Safety. 2026;35(11). doi:10.1002/pds.70519
BibTeX
@article{Desaunay2026,
author = {Desaunay, Pierre and Blouet, Camille and Guenole, Fabian},
title = {Letter to the Editor Regarding “Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden” by Martin et al. (2026)},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
volume = {35},
number = {11},
doi = {10.1002/pds.70519}
}
EUVIMED